Llwytho...
Blocking the Leukotriene B4 Receptor 1 Inhibits Late-Phase Airway Responses in Established Disease
Most of the studies investigating the effectiveness of blocking the leukotriene B4 (LTB4) receptor 1 (BLT1) have been performed in models of primary or acute allergen challenge. The role of the LTB4-BLT1 pathway in secondary challenge models, where airway hyperresponsiveness (AHR) and airway inflamm...
Wedi'i Gadw mewn:
Prif Awduron: | , , , , , , , , , , |
---|---|
Fformat: | Artigo |
Iaith: | Inglês |
Cyhoeddwyd: |
American Thoracic Society
2011
|
Pynciau: | |
Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3208610/ https://ncbi.nlm.nih.gov/pubmed/21421908 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1165/rcmb.2010-0455OC |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|